Maxcyte shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Maxcyte
Tip: Access up to 7 years of quarterly data
All positions including Maxcyte held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Maxcyte by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $695k | 148k | 4.70 |
| 2023-09-30 | $462k | 148k | 3.12 |
| 2023-06-30 | $308k | 62k | 4.95 |
| 2023-03-31 | $308k | 62k | 4.95 |
| 2022-12-31 | $343k | 63k | 5.46 |
| 2022-09-30 | $409k | 63k | 6.50 |
| 2022-06-30 | $298k | 63k | 4.73 |
| 2022-03-31 | $322k | 46k | 6.99 |
| 2021-12-31 | $469k | 46k | 10.19 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas